1. Home
  2. MEOH vs ARQT Comparison

MEOH vs ARQT Comparison

Compare MEOH & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEOH
  • ARQT
  • Stock Information
  • Founded
  • MEOH 1968
  • ARQT 2016
  • Country
  • MEOH Canada
  • ARQT United States
  • Employees
  • MEOH N/A
  • ARQT N/A
  • Industry
  • MEOH Major Chemicals
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEOH Industrials
  • ARQT Health Care
  • Exchange
  • MEOH Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • MEOH 1.8B
  • ARQT 1.5B
  • IPO Year
  • MEOH N/A
  • ARQT 2020
  • Fundamental
  • Price
  • MEOH $31.07
  • ARQT $14.61
  • Analyst Decision
  • MEOH Buy
  • ARQT Strong Buy
  • Analyst Count
  • MEOH 8
  • ARQT 6
  • Target Price
  • MEOH $49.50
  • ARQT $18.80
  • AVG Volume (30 Days)
  • MEOH 731.6K
  • ARQT 2.5M
  • Earning Date
  • MEOH 05-02-2025
  • ARQT 05-06-2025
  • Dividend Yield
  • MEOH 2.40%
  • ARQT N/A
  • EPS Growth
  • MEOH N/A
  • ARQT N/A
  • EPS
  • MEOH 2.39
  • ARQT N/A
  • Revenue
  • MEOH $3,719,829,000.00
  • ARQT $196,542,000.00
  • Revenue This Year
  • MEOH $17.69
  • ARQT $57.99
  • Revenue Next Year
  • MEOH $5.92
  • ARQT $41.24
  • P/E Ratio
  • MEOH $12.90
  • ARQT N/A
  • Revenue Growth
  • MEOH N/A
  • ARQT 229.74
  • 52 Week Low
  • MEOH $25.46
  • ARQT $6.99
  • 52 Week High
  • MEOH $56.43
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • MEOH 47.82
  • ARQT 52.13
  • Support Level
  • MEOH $26.47
  • ARQT $12.51
  • Resistance Level
  • MEOH $31.32
  • ARQT $15.02
  • Average True Range (ATR)
  • MEOH 1.76
  • ARQT 1.13
  • MACD
  • MEOH 0.83
  • ARQT 0.09
  • Stochastic Oscillator
  • MEOH 95.73
  • ARQT 82.83

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: